Q
QuantAbundanciaAbundância, quantificada.

Notícias

Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.

27,451 signal articles · 236 in last 24h · 132,834 total before filter · latest 56m ago
236last 24h
1169last 7d
204● bullish (7d)
124● bearish (7d)
208publishers
AllMacro282Earnings427M&A72Regulatory22Product10Analyst20
✕ clear all filtersSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
1 Value Stock with Impressive Fundamentals and 2 We Question
StockStory2h agoneutral
1 Value Stock with Impressive Fundamentals and 2 We Question

The low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer. However, the challenge lies in determining whether these cheap assets are genuinely undervalued or simply on sale due to their potentially deteriorating business models.

Snowflake Q2 Earnings Call Highlights
MarketBeat3h agoneutral
Snowflake Q2 Earnings Call Highlights

Snowflake (NYSE:SNOW) reported accelerating second-quarter fiscal 2027 growth as demand for its core data platform and AI products increased, while the company also expanded its non-GAAP operating margin and raised its full-year product revenue outlook. Product revenue totaled $1.49 billion, up 37%

Hewlett Packard Enterprise Q3 Earnings Call Highlights
MarketBeat3h agoneutral
Hewlett Packard Enterprise Q3 Earnings Call Highlights

Hewlett Packard Enterprise (NYSE:HPE) reported record fiscal 2026 third-quarter results, citing accelerating demand for AI infrastructure, continued networking momentum and disciplined pricing. The company also raised its fiscal 2026 outlook and updated its fiscal 2027 growth framework as orders out

Broadcom Q3 Earnings Call Highlights
MarketBeat3h agoneutral
Broadcom Q3 Earnings Call Highlights

Broadcom (NASDAQ:AVGO) reported record third-quarter fiscal 2026 revenue, operating income and free cash flow, driven by sharply higher demand for artificial intelligence semiconductors and custom AI accelerators. Revenue rose 86% year over year to $29.6 billion, while operating income increased 92

1 Software Stock Worth Investigating and 2 We Avoid
StockStory3h agoneutral
1 Software Stock Worth Investigating and 2 We Avoid

From commerce to culture, software is digitizing every aspect of our lives. The undeniable tailwinds fueling the industry have also led to strong returns for SaaS stocks lately as they’ve gained 47.6% over the past six months, outpacing the S&P 500’s 12.3% rise.

1 Mid-Cap Stock on Our Watchlist and 2 We Avoid
StockStory3h agoneutral
1 Mid-Cap Stock on Our Watchlist and 2 We Avoid

Mid-cap stocks often strike the right balance between having proven business models and market opportunities that can support $100 billion corporations. However, they face intense competition from scaled industry giants and can be disrupted by new innovative players vying for a slice of the pie.

Investing.com3h agoneutral
Nscale doubles contracted revenue to $103 billion after Anthropic win - report

Investing.com -- UK-based neocloud provider Nscale is informing prospective investors that its total contracted revenue has expanded to approximately $103 billion, bolstered by a landmark $45 billion computing deal with Anthropic, according to investor materials reviewed by The Information. The Nvidia-backed infrastructure firm could launch an initial public offering as soon as this month, utilizing the massive backlog to demonstrate sustained enterprise demand for specialized artificial intelli

Snap (SNAP) Moved, So Why Is It Back In Focus?
Simply Wall St.3h agoneutral
Snap (SNAP) Moved, So Why Is It Back In Focus?

Why Snap Stock Is Back In Focus After Its Latest Earnings Report Snap (SNAP) is drawing fresh attention after its latest earnings report, which combined 19% year over year revenue growth with a very large jump in adjusted EBITDA, even as the share price has declined about 7.6%. At a share price of $5.59, Snap has seen a 1 month share price return of 10.9%. However, the year to date share price return is down 31.2% and the 5 year total shareholder return is down 92.5%, which points to fading...

American Airlines (AAL) Stock May Be Undervalued Given Sales And Debt Risk
Simply Wall St.3h agoneutral
American Airlines (AAL) Stock May Be Undervalued Given Sales And Debt Risk

American Airlines Group stock has fallen over the past few years, yet the broader valuation checks currently lean cheap relative to where the market has priced the shares. The share price is down 31.5% over 5 years, which means long term holders have seen a material capital decline. Future earnings and cash flow can be influenced by efficient fleet use and cost discipline, while high debt levels remain a key risk if conditions weaken. The broader checks lean cheap, with American Airlines...

The Bull Case For Cigna Group (CI) Could Change Following Its New Connected Benefits Platform Launch
Simply Wall St.3h agoneutral
The Bull Case For Cigna Group (CI) Could Change Following Its New Connected Benefits Platform Launch

Cigna Healthcare recently introduced an industry-first connected benefits experience that links medical and supplemental health coverage to simplify access to cash benefits for unexpected health events, with Medical with Smart Coverage slated to begin offering supplemental cash of up to US$7,000 per covered event from January 2027 for eligible mid-sized employer plans. This move directly addresses widespread gaps in Americans’ financial readiness for medical shocks and the underuse of...

Is Amgen (AMGN) Reasonable Or Rich As Cash Flow Improves?
Simply Wall St.3h agoneutral
Is Amgen (AMGN) Reasonable Or Rich As Cash Flow Improves?

Amgen stock has logged a strong 5 year run, yet current valuation checks send mixed signals as the intrinsic value estimate suggests a discount while market based multiples look closer to fair. Over 5 years, Amgen has returned 134.2%, which means anyone looking at the stock today is weighing fresh gains against the chance that the easy part of the move is already behind it. New clinical data around Repatha and Tezspire can support expectations for future cash flows, while ongoing trial and...

PepsiCo (PEP) Faces Ukraine Damage And Soft Demand, Is The Stock Undervalued?
Simply Wall St.3h agoneutral
PepsiCo (PEP) Faces Ukraine Damage And Soft Demand, Is The Stock Undervalued?

PepsiCo (PEP) is in a transitional phase after conflict related damage at a Ukrainian production facility and softer demand in North America, which is putting more attention on how its stock reflects these operational pressures. Over the past year, PepsiCo’s share price return and its 1 year total shareholder return have both slipped slightly. Together with softer North American demand and the recent Ukrainian facility damage, this has cooled momentum even as the company signs new...

Investing.com3h agoneutral
JPMorgan scales back Jane Street financing amid growing bond market rivalry - FT

Investing.com -- JPMorgan Chase & Co (NYSE:JPM) has scaled back the financing extended to Jane Street following the quantitative trading giant's expansion into U.S. Treasury market-making, according to a report from the Financial Times. The decision highlights mounting friction between Wall Street's legacy dealers and the non-bank trading firms increasingly capturing market share across fixed-income markets. The financing reduction represented roughly 5% of Jane Street's overall fixed-income cre